Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The need for physiological phenotyping to develop new drugs for airways disease.

Pharmacological research - 1 Sept 2020

Chapman David G, King G G, Robinson Paul D, Farah Claude S, Thamrin Cindy

Abstract excerpt

Asthma and COPD make up the majority of obstructive airways diseases (OADs), which affects ∼11 % of the population. The main drugs used to treat OADs have not changed in the past five decades, with advancements mainly comprising variations on existing treatments. The recent biologics are beneficial to only specific subsets of patients. Part of this may lie in our inability to adequately characterise the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making
Share to Airway Obstruction
Share to Drug Development

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Diseases, Obstructive

Share to Patient Reported Outcome Measures

Share to Predictive Value of Tests

Share to Respiratory Function Tests

Source

Identifiers

PMID: 32565310
DOI: 10.1016/j.phrs.2020.105029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The need for physiological phenotyping to develop new drugs for airways disease.PMID 32565310Read ↗

Asthma Phenotypes and Endotypes: Implications for Personalised Therapy.Semantic proximity Read ↗

Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.Semantic proximity Read ↗

Chronic obstructive pulmonary disease subpopulations and phenotyping.Semantic proximity Read ↗

WITHDRAWN: Small Airway Physiological Signatures of Response to Biologic Therapy in Severe AsthmaSemantic proximity Read ↗

Current Approaches for Phenotyping as a Target for Precision Medicine in COPD Management.Semantic proximity Read ↗

Respiratory Oscillometry and Functional Performance in Different COPD Phenotypes.Semantic proximity Read ↗

A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future.Semantic proximity Read ↗

Phenotyping Before Starting Treatment in COPD?Semantic proximity Read ↗

From ideal respiratory health to chronic lung disease: indicators of impaired respiratory health.Semantic proximity Read ↗

Treatable traits of chronic airways disease.Semantic proximity Read ↗

Physiological and biological characterization of smokers with and without COPDSemantic proximity Read ↗

Personalized medicine targeting different ARDS phenotypes: The future of pharmacotherapy for ARDS?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.